Gilead Sciences Inc (NASDAQ:GILD)

During the Trading Day
100.58 -0.01 / -0.01%
Data as of 4:14pm ET
Day’s Change
During After-Hours   Switch to standard view »
100.45 -0.13 / -0.13%
Volume: 223.1K
Buy Gilead Sciences
9:32am /
Trading Activity
Nov 14 / StockTwits
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog
Nov 20 /
Why Gilead Sciences (GILD) Isn't Done Growing Earnings Yet - Tale of the Tape
Nov 13 /
Biotech's 3 Most Influential CEOs
Nov 20 /
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog
Nov 12 /
CNBC's Stock Pops & Drops From November 19
Nov 20 / Benzinga
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bank...
Nov 12 /
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog
Nov 19 /
This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
Nov 12 /
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in th...
Nov 19 /
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog
Nov 11 /
Stock Market News for November 19, 2014 - Market News
Nov 19 /
Achillion Jumps on Encouraging Data on its HCV Candidate - Analyst Blog
Nov 11 /
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High
Nov 18 /
Conatus Pharmaceuticals (CNAT): Will Loss Narrow in Q3? - Analyst Blog
Nov 11 /
Front Runners: TerraForm Power (TERP), Virgin America (VA), Abengoa SA (ABGB), Gilead...
Nov 18 / Investing Channel
Stock Market News for November 11, 2014 - Market News
Nov 11 /
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide
Nov 18 /
Gilead Sciences Inc. Breathes a Sigh of Relief -- Hepatitis C Patients, Not So Much
Nov 11 /
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for...
Nov 18 /
Merck Reports Interim Data on Hepatitis C Virus Drug - Analyst Blog
Nov 10 /
Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More
Nov 17 /
3 Drugs That Make Gilead Sciences' Harvoni Look Cheap
Nov 10 /
3 Stocks Reiterated As A Buy: GE, GILD, PG
Nov 17 /
October jitters are just a taste things to come
Nov 10 /
AZN, PFE And GILD, 3 Drugs Stocks Pushing The Industry Lower
Nov 17 /
5 Prescription Drugs Selling Like Hot Cakes
Nov 09 /
Stock Market News for November 17, 2014 - Market News
Nov 17 /
Gilead (GILD) Submits HIV Combination Drug for FDA Review - Analyst Blog
Nov 09 /
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
Nov 17 /
Gilead Sciences Popular Amongst Latest 13F Filers
Oct 31 /
3 Stocks the Smartest Investors Are Buying Right Now
Nov 17 /
Electronic Arts climbs on strong earnings
Oct 29 /
Healthy Returns From The Healthcare Sector
Nov 16 / Investing Channel
Gilead's latest hepatitis C drug breaks US sales records
Oct 28 /
These Two Look Tempting
Nov 16 /
Friday Sector Leaders: Healthcare, Utilities
Oct 24 /
The Fab 5 Update
Nov 15 / StockTwits
Progress against Aids spurs GSK plan to float ViiV Healthcare
Oct 24 /
Julian Robertson's Tiger Management 13F Reveals Huge Alibaba Stake
Nov 15 / Benzinga

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.